Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Sunday, November 1, 2026

Back to today

From X

@convequity

Convequity on X

I'm surprised $AMZN leadership ever judged performance on token usage. It's a primitive metric. Tokens tell you what the AI cost. They say nothing about what it delivered. The measure that matters is ROI: outcomes against tokens, set for each function. Developers: DORA metrics against tokens. Deployment frequency, lead time, change failure rate and recovery time. Sales and marketing: pipeline and closed deals against tokens. Project teams: revenue earned or costs cut against tokens. IT: network and system performance against tokens. Uptime, latency and incidents. Faros, LinearB, DX and Jellyfish already set token spend against engineering output. I haven't seen anyone do it across the whole business in a way a CFO would trust. Whoever builds that can sell to every company with a rising AI bill.
@convequity 1 click

Convequity on X

Strange short report on Cerebras $CBRS. Wafer-scale power and thermal constraints are longstanding engineering challenges. They can force compromises on clock speed versus a smaller die. That doesn't mean unacceptable overall performance. CS-4 is getting more out of WSE-3T, with the same core count and SRAM capacity as WSE-3, through higher clocks and improved I/O. Cerebras attributes the higher clocks to better power delivery. My read is that earlier systems left performance on the table to stay within power and thermal limits. Directionally, Cerebras looks to be working through those constraints better than I expected. Higher clocks alone don't answer the lifespan allegation. I’d still want to know how representative those failures are of current systems. I also give weight to Oracle, OpenAI and AWS choosing to work with Cerebras.
@BrokenMoats

Broken Moats on X

$now bill is always selling and some people on here seem confused why the stock is down when they look at the numbers he directs you to. Wash away all of his puffery and the underlying business deteriorated - gross profit came in at 10%+ yoy (which I believe is the lowest ever) for the quarter. You can call anything revenue but it's ultimately about the gross profit dollars you bring in + the efficiency of your expense management, which if you look saw increases across the board with profit materially weakening. You can argue intangibles on the COGS but then you need to adjust the light crpo further to exclude all the inorganic revenue helping out in there (which the co did not strip out).....the street is not fooled, these were not great numbers. And swapping revenue to juice AI in a press release while total sales stays on trend is not going to work anymore, as one analyst put it best to Bill "I wanted to just zoom out a little bit and just talk about the momentum you're seeing on the AI ACV side. Gina as you noted, you've raised the guidance twice now to $1.7 billion in revenue. At the same time, if we look at just the broad story of cRPO, we could call it stable, maybe on an organic basis, modestly decelerating, but sort of generally stable. So my high-level question, Bill, is just when do you think the AI momentum will start to translate to overall top line acceleration, cRPO acceleration?" There are very different expectations when a stock doubles in a quarter in-between reporting results.....

Investor Letters

All letters

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

MO $130B
Invariant 2 clicks

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B
John Hempton's Newsletter 3 clicks

Verra veerer

Verra Mobility’s Avis termination threatens 2027 earnings, while Government Solutions profit rose 25% and implied fourth-quarter guidance…

VRRM $505M
The Oak Bloke 2 clicks

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $16B
Stock Thoughts 4 clicks

Microsoft's AI Boom Has A Cost

Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…

MSFT $3.9T
Yiannis Zourmpanos 2 clicks
T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

T $144B
Value Investors Club

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $465B
Cestrian Capital Research 3 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $108B
Cestrian Capital Research 1 click

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 269

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.